Upper endoscopy with biopsy
Facility: Kansas City Orthopaedic Institute
Billing Code: 43239 (CPT)
- CPT Billing Code: 43239
- Insurance Median: $2,092
- Cash Discount Price: Unavailable
- vs. Medicare Baseline: 2.26x Medicare
Average discount available for prompt cash payment at this facility.
Median negotiated contract rate across all mapped commercial carriers.
Standard federal government reimbursement rate for this code.
Visual Cost Comparison vs. Medicare
Understanding this gauge: We use the federal Medicare rate of $926.63 as the cost baseline. Rates below the baseline represent excellent value. In-network commercial rates commonly hover around 150% - 250% of Medicare, while rates exceeding 300% are elevated. Hover over the green and blue markers to view detailed calculations.
Elevated Commercial Rate Alert (Value-Gap)
The negotiated rate at this facility is 226% of the Medicare baseline (a markup of 126%). Patients with high-deductible plans or out-of-network benefits may face excessive out-of-pocket costs.
Out-of-Pocket Cost Estimator
Estimate whether it is more economical to use your insurance or pay the upfront self-pay cash rate.
Commercial Insurance Negotiated Rates
Negotiated contract ranges established by major commercial carriers at this facility.
| Carrier / Plan Group | Contract Rate Range | vs. Medicare Reference |
|---|---|---|
| Aetna | $805 | 87% |
| UnitedHealthcare | $805 | 87% |
| Cigna | $882 | 95% |
| Blue Cross Blue Shield | $2,092 | 226% |
Consumer Guidance & Cost Commentary
For the procedure "Upper endoscopy with biopsy" at Kansas City Orthopaedic Institute in Leawood, KS, the facility's negotiated rate is $2,092, which is significantly higher than the state average of $926.63 (Medicare amount). This facility is owned by a physician group and serves four payers, including Aetna, UnitedHealthcare, Cigna, and Blue Cross Blue Shield, all of which have a fixed negotiated rate of $805 to $882 depending on the specific plan. While these rates are lower than the facility's full negotiated amount, they still exceed the Medicare benchmark by a factor of 2.3, indicating a substantial markup over the federal cost baseline. Patients should be aware that commercial insurance rates often include administrative overhead and contract premiums that do not reflect the true cost of care, making it essential to compare these figures against the state average to understand the full scope of pricing.
To potentially lower costs, patients should inquire about "self-pay" or "prompt-pay" discounts before scheduling, as paying upfront can sometimes bypass the higher insurance negotiated rates, particularly if the patient has a high deductible. It is also important to request an itemized billing audit to ensure no errors, unbundled codes, or services not rendered are included in the final charge, as over 80% of hospital bills contain discrepancies that can be corrected. While the No Surprises Act protects patients from balance billing for out-of-network services at in-network facilities, verifying the exact status of all ancillary services remains crucial. Ultimately, understanding the difference between the Medicare benchmark, state averages, and negotiated rates empowers consumers to make informed decisions about their healthcare spending.